Cargando…

RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?

The COVID-19 pandemic demonstrates the ongoing threat of pandemics caused by novel, previously unrecognized, or mutated pathogens with high transmissibility. Currently, vaccine development is too slow for vaccines to be used in the control of emerging pandemics. RNA-based vaccines might be suitable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sandbrink, Jonas B., Shattock, Robin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783390/ https://www.ncbi.nlm.nih.gov/pubmed/33414790 http://dx.doi.org/10.3389/fimmu.2020.608460

Ejemplares similares

Promoting versatile vaccine development for emerging pandemics
por: Monrad, Joshua T., et al.
Publicado: (2021)

Biosecurity risks associated with vaccine platform technologies
por: Sandbrink, Jonas B., et al.
Publicado: (2022)

Toxicological Assessments of a Pandemic COVID-19 Vaccine—Demonstrating the Suitability of a Platform Approach for mRNA Vaccines
por: Rohde, Cynthia M., et al.
Publicado: (2023)

Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity
por: Fennemann, Felix L., et al.
Publicado: (2019)

Tackling variants with antibodies
por: Aitken, Elizabeth H, et al.
Publicado: (2022)

Literature Mining and Mechanistic Graphical Modelling to Improve mRNA Vaccine Platforms
por: Leonardelli, Lorena, et al.
Publicado: (2021)

Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination
por: Kratochvil, Sven, et al.
Publicado: (2017)

Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings
por: Vázquez-Maldonado, Nancy, et al.
Publicado: (2023)

Corrigendum: Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination
por: Kratochvil, Sven, et al.
Publicado: (2018)

Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
por: Kis, Zoltán, et al.
Publicado: (2020)

Tackling Chronic Kidney Transplant Rejection: Challenges and Promises
por: Lai, Xingqiang, et al.
Publicado: (2021)

Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in Humans
por: Anderson, Jenna, et al.
Publicado: (2018)

Bacteriophage T4 Vaccine Platform for Next-Generation Influenza Vaccine Development
por: Li, Mengling, et al.
Publicado: (2021)

COVID-19 and Health Code: How Digital Platforms Tackle the Pandemic in China
por: Liang, Fan
Publicado: (2020)

Innovate and Stockpile: Respiratory Protection for Essential Workers in a Catastrophic Pandemic
por: Montazeri, Nadia X., et al.
Publicado: (2023)

Glucocorticoids—All-Rounders Tackling the Versatile Players of the Immune System
por: Strehl, Cindy, et al.
Publicado: (2019)

Suitability of potyviral recombinant virus-like particles bearing a complete food allergen for immunotherapy vaccines
por: Pazos-Castro, Diego, et al.
Publicado: (2022)

Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination
por: Messina, Nicole L., et al.
Publicado: (2023)

Novel Platforms for the Development of a Universal Influenza Vaccine
por: Kumar, Arun, et al.
Publicado: (2018)

Correction: Kis, Z. et al. Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand. Vaccines 2021, 9, 3
por: Kis, Zoltán, et al.
Publicado: (2021)

Saliva is suitable for SARS-CoV-2 antibodies detection after vaccination: A rapid systematic review
por: Guerra, Eliete Neves Silva, et al.
Publicado: (2022)

Corrigendum: Suitability of potyviral recombinant virus-like particles bearing a complete food allergen for immunotherapy vaccines
por: Pazos-Castro, Diego, et al.
Publicado: (2023)

A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis Clearance
por: Badamchi-Zadeh, Alexander, et al.
Publicado: (2016)

Tackling vaccine refusal
por: Gordijn, Bert, et al.
Publicado: (2022)

An Integrated Platform for Serological Detection and Vaccination of COVID-19
por: Wei, Sung-Chan, et al.
Publicado: (2021)

Virus like particles as a platform for cancer vaccine development
por: Ong, Hui Kian, et al.
Publicado: (2017)

Advances in Bovine Immunology – New Tools and New Insights to Tackle Old Foes
por: Meade, Kieran G.
Publicado: (2015)

The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer
por: Subtil, Beatriz, et al.
Publicado: (2021)

mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic
por: Xu, Ziyang, et al.
Publicado: (2023)

Challenges of tackling non COVID-19 emergencies during the unprecedent pandemic
por: Mukunya, David, et al.
Publicado: (2020)

Bacterial outer membrane vesicles as a candidate tumor vaccine platform
por: Wang, Shuming, et al.
Publicado: (2022)

Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy
por: Santos, Susana, et al.
Publicado: (2022)

A platform technology for generating subunit vaccines against diverse viral pathogens
por: Young, Andrew, et al.
Publicado: (2022)

Characterization of Bacillus anthracis Spore Proteins Using a Nanoscaffold Vaccine Platform
por: Weilhammer, Dina R., et al.
Publicado: (2020)

Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
por: Gallinaro, Alessandra, et al.
Publicado: (2018)

Self-assembled nanoparticles: A new platform for revolutionizing therapeutic cancer vaccines
por: Shi, Tianyu, et al.
Publicado: (2023)

Tackling the COVID-19 Pandemic
por: Rahimi, Farid, et al.
Publicado: (2020)

Platforms, advances, and technical challenges in virus-like particles-based vaccines
por: Gupta, Reeshu, et al.
Publicado: (2023)

Chicken antibodies are highly suitable for particle enhanced turbidimetric assays
por: Larsson, Anders, et al.
Publicado: (2022)

Development of a Potential Yeast-Based Vaccine Platform for Theileria parva Infection in Cattle
por: Goh, Shan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r9e2sfcvf1r8hn1i9fu59mg78c